NDC 70677-1230-01 - Foster and Thrive Maximum Strength Urinary Pain Relief
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70677-1230
- Requested NDC
- 70677-1230-01
- Package NDCs from labels
- 70677-1230-1, 70677-1230-01
- Manufacturer
- Sportpharm LLC
- Effective date
- 2026-10-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Foster and Thrive Maximum Strength Urinary Pain Relief - Sportpharm LLC | Sportpharm LLC | 2026-10-06 | HUMAN OTC DRUG LABEL |
| PHENAZOPYRIDINE - Strategic Sourcing Services LLC | Reese Pharmaceutical Co | Strategic Sourcing Services LLC | Reese Pharmaceutical Co | 2024-06-21 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70677-1230-1 | Foster and Thrive Maximum Strength Urinary Pain Relief | 12 in 1 BLISTER PACK | TABLET | 12 | 5 | |
| 70677-1230-1 | Foster and Thrive Maximum Strength Urinary Pain Relief | 1 in 1 CARTON | TABLET | 1 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70677-1230 | FOSTER AND THRIVE MAXIMUM STRENGTH URINARY PAIN RELIEF (PHENAZOPYRIDINE HYDROCHLORIDE) TABLET [STRATEGIC SOURCING SERVICES LLC] | 5 | Current NDC, 2 package rows | 20240622_97ea2a3e-c1a0-437d-ac2a-2128e193183b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70677-1230-1 | EA - Each | 70677-1230 | d5f1dc61-7293-4465-a7ac-cc6e4e4fd66c | 1 | 2024-10-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cystex Max UTI Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Clarion Brands, LLC | a4d34c20-62af-4a3c-ad2c-046ba08d1ef6 | 2026-11-09 | Warnings | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | PD-Rx Pharmaceuticals, Inc. | 1522921b-d6c2-420d-ba0d-39ac16ba8b37 | 2026-10-30 | Adverse reactions | 0EWG668W17 |
| Cystex Max Strength UTI Pain Relief | CYSTEX MAX STRENGTH UTI PAIN RELIEF | Clarion Brands LLC | 57482f71-80d3-b20d-e063-6394a90a0cf4 | 2026-10-28 | Warnings | 1094147 0EWG668W17 |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | FZ989GH94E |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-10-14 | Warnings | 3NXW29V3WO |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 5dd1e5aa-df98-8482-e063-6294a90a878d | 2026-10-14 | Warnings, Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | PD-Rx Pharmaceuticals, Inc. | c1591037-62f4-469f-8bb2-a82e49dfbecf | 2026-10-12 | Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | Preferred Pharmaceuticals Inc. | 132cc592-6b03-4b75-bf39-df476fb9dc81 | 2026-10-09 | Adverse reactions | 0EWG668W17 |
| Foster and Thrive Neighbor Pharmacy Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Redpharm Drug | 5d629ecc-c737-05f6-e063-6294a90a4390 | 2026-10-09 | Warnings | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ce702be2-eec2-4346-965e-f1f6ba342fc9 | 2026-10-09 | Warnings, Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc | 96308f8c-66e7-486a-a5c0-ee9a133ad051 | 2026-10-09 | Warnings, Adverse reactions | 0EWG668W17 |
| Foster and Thrive Maximum Strength Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Sportpharm LLC | 42abac37-557f-4372-b55a-12ddae71ec8b | 2026-10-06 | Warnings | 85766-300-12 85766-300 1094147 5d2599ef-b9d6-70c7-e063-6294a90adbe1 42abac37-557f-4372-b55a-12ddae71ec8b 0EWG668W17 |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | ETJ7Z6XBU4 |
| REFRESH Classic | POLYVINYL ALCOHOL, POVIDONE | Allergan, Inc. | 31bf1d6c-9719-4060-b6a3-409a2fe7b560 | 2026-09-15 | Warnings | FZ989GH94E |
| Leader Artificial Tears 15 mL | POLYVINYL ALCOHOL, POVIDONE | Cardinal Health | 8cccc589-3a8e-baad-e053-2a95a90ab8c7 | 2026-09-09 | Warnings | FZ989GH94E |
| Psoriasis Control | CENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDE | Forces of Nature | 2db33771-0bb9-49f8-84fa-dddc28e4ba26 | 2026-09-04 | Warnings | ETJ7Z6XBU4 |
| FRESHKOTE PRESERVATIVE FREE LUBRICANT EYE DROPS | POVIDONE, POLYVINYL ALCOHOL SOLUTION | Harrow Eye, LLC | 049e9cc9-0663-53bc-e063-6294a90a2c4f | 2026-09-04 | Warnings | FZ989GH94E |
| BMNP Silicea | SILICEA | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a58454f-aed6-24ba-e063-6294a90a47fb | 2026-08-31 | Warnings | ETJ7Z6XBU4 |
| Argentum Quartz | ARGENTUM QUARTZ | Uriel Pharmacy Inc. | 765c8c8f-0727-45da-a77e-c3907a3d0793 | 2026-08-26 | Warnings | ETJ7Z6XBU4 |
| Endometrium Argentum | ENDOMETRIUM ARGENTUM | Uriel Pharmacy Inc | d2d1428a-c8b5-9529-e053-2995a90a2343 | 2026-08-26 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.